LINGLE BRANDAN 4
4 · Surgery Partners, Inc. · Filed Mar 19, 2019
Insider Transaction Report
Form 4
LINGLE BRANDAN
Pres., Ancillary Svces. Grp.
Transactions
- Award
Stock Option (Right to Buy)
2019-03-15+102,000→ 102,000 totalExercise: $13.42Exp: 2029-03-15→ Common Stock (102,000 underlying) - Award
Common Stock
2019-03-15+5,830→ 27,346 total - Award
Common Stock
2019-03-15+7,451→ 34,797 total - Tax Payment
Common Stock
2019-03-16$13.42/sh−555$7,448→ 34,242 total - Tax Payment
Common Stock
2019-03-17$13.42/sh−955$12,816→ 33,287 total
Footnotes (5)
- [F1]Shares issued based on 2018 performance under performance stock unit awards granted to the Reporting Person on March 16, 2018. Shares will vest in two equal annual installments on each of the first two anniversaries of December 31, 2018.
- [F2]Shares will vest in three equal annual installments of each of the first three anniversaries of March 16, 2019.
- [F3]Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 16, 2019 of restricted stock.
- [F4]Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 17, 2019 of restricted stock.
- [F5]One-third (1/3) of the options will vest in three equal installments on each of December 31, 2020, December 31, 2021, and December 31, 2022, generally contingent upon continued employment through each applicable vesting date (the "time condition"). One-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $25.00. The remaining one-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $35.00.